Annual Drug Patent Expirations for COSELA
Cosela is a drug marketed by G1 Therap and is included in one NDA. There are eight patents protecting this drug.
This drug has ninety-six patent family members in twenty-five countries.
The generic ingredient in COSELA is trilaciclib dihydrochloride. Additional details are available on the trilaciclib dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
